Tackling Inflammatory Bowel Diseases: Targeting Proinflammatory Cytokines and Lymphocyte Homing

Inflammatory bowel diseases (IBDs) are characterized by chronic inflammatory disorders that are a result of an abnormal immune response mediated by a cytokine storm and immune cell infiltration. Proinflammatory cytokine therapeutic agents, represented by TNF inhibitors, have developed rapidly over r...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Yijie, Yuan, Man, Xu, Yu, Xu, Hongxi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502105/
https://www.ncbi.nlm.nih.gov/pubmed/36145301
http://dx.doi.org/10.3390/ph15091080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502105/
https://www.ncbi.nlm.nih.gov/pubmed/36145301
http://dx.doi.org/10.3390/ph15091080

Ejemplares similares